Total Payments
$38,225
2024 Payments
$1,983
Companies
42
Transactions
985
Medicare Patients
3,132
Medicare Billing
$271,514
Payment Breakdown by Category
Other$20,000 (52.3%)
Food & Beverage$17,769 (46.5%)
Travel$305.77 (0.8%)
Education$149.83 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20,000 | 11 | 52.3% |
| Food and Beverage | $17,769 | 961 | 46.5% |
| Travel and Lodging | $305.77 | 7 | 0.8% |
| Education | $149.83 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $23,729 | 145 | $0 (2024) |
| GlaxoSmithKline, LLC. | $5,873 | 405 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,024 | 53 | $0 (2024) |
| Genentech USA, Inc. | $773.02 | 45 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $682.31 | 38 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $637.33 | 41 | $0 (2024) |
| United Therapeutics Corporation | $579.84 | 5 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $430.16 | 35 | $0 (2021) |
| Mylan Specialty L.P. | $372.99 | 20 | $0 (2024) |
| Insmed, Inc. | $296.50 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,983 | 101 | GlaxoSmithKline, LLC. ($752.84) |
| 2023 | $4,001 | 98 | AstraZeneca Pharmaceuticals LP ($2,652) |
| 2022 | $10,551 | 116 | AstraZeneca Pharmaceuticals LP ($9,024) |
| 2021 | $2,416 | 81 | AstraZeneca Pharmaceuticals LP ($1,316) |
| 2020 | $10,143 | 81 | AstraZeneca Pharmaceuticals LP ($9,337) |
| 2019 | $3,287 | 199 | GlaxoSmithKline, LLC. ($1,045) |
| 2018 | $2,801 | 162 | GlaxoSmithKline, LLC. ($931.48) |
| 2017 | $3,043 | 147 | United Therapeutics Corporation ($579.84) |
All Payment Transactions
985 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $33.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $12.84 | General |
| Category: HFCWO | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 833 | 965 | $166,662 | $67,997 |
| 2022 | 10 | 912 | 1,066 | $182,540 | $80,540 |
| 2021 | 12 | 751 | 858 | $149,800 | $70,321 |
| 2020 | 15 | 636 | 696 | $119,811 | $52,656 |
Total Patients
3,132
Total Services
3,585
Medicare Billing
$271,514
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 227 | 312 | $62,808 | $31,981 | 50.9% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 104 | 107 | $25,145 | $12,071 | 48.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 120 | 129 | $20,640 | $6,166 | 29.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 121 | 130 | $15,860 | $4,833 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $7,610 | $3,053 | 40.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 83 | 88 | $14,080 | $2,936 | 20.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 109 | 124 | $12,400 | $2,830 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 19 | $5,168 | $2,807 | 54.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 14 | 18 | $2,340 | $1,137 | 48.6% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 13 | 13 | $611.00 | $182.88 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 232 | 346 | $65,740 | $35,897 | 54.6% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 156 | 168 | $39,480 | $18,266 | 46.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $11,310 | $5,341 | 47.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 107 | 111 | $16,095 | $5,335 | 33.1% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 109 | 113 | $12,430 | $4,094 | 32.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 26 | $6,630 | $3,670 | 55.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 106 | 109 | $16,895 | $3,625 | 21.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 85 | 93 | $8,835 | $2,227 | 25.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 22 | 28 | $3,640 | $1,590 | 43.7% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 33 | 33 | $1,485 | $495.02 | 33.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 237 | 302 | $57,380 | $31,599 | 55.1% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 145 | 157 | $36,895 | $17,440 | 47.3% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 83 | 89 | $12,533 | $4,379 | 34.9% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2021 | 82 | 88 | $9,497 | $3,383 | 35.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 22 | 24 | $6,120 | $3,364 | 55.0% |
About Dr. Eric Shore, MD
Dr. Eric Shore, MD is a Pulmonary Disease healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932203494.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Shore, MD has received a total of $38,225 in payments from pharmaceutical and medical device companies, with $1,983 received in 2024. These payments were reported across 985 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($20,000).
As a Medicare-enrolled provider, Shore has provided services to 3,132 Medicare beneficiaries, totaling 3,585 services with total Medicare billing of $271,514. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Hartford, CT
- Active Since 09/12/2006
- Last Updated 12/07/2010
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1932203494
Products in Payments
- BREZTRI (Drug) $12,608
- BREZTRI AEROSPHERE (Drug) $9,087
- TRELEGY ELLIPTA (Drug) $2,544
- NUCALA (Biological) $1,718
- FASENRA (Drug) $658.65
- XOLAIR (Biological) $622.89
- ORENITRAM (Drug) $579.84
- Xolair (Biological) $512.06
- OFEV (Drug) $505.82
- SYMBICORT (Drug) $485.60
- ANORO (Drug) $462.36
- TEZSPIRE (Biological) $423.54
- ACTHAR (Biological) $420.83
- GLASSIA (Biological) $409.95
- FASENRA (Biological) $378.20
- BREO (Drug) $366.57
- DUPIXENT (Biological) $311.74
- UPTRAVI (Drug) $303.33
- LONHALA MAGNAIR (Drug) $302.47
- STIOLTO RESPIMAT (Drug) $270.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Hartford
Daniel Gerardi, Md, MD
Pulmonary Disease — Payments: $131,554
Pulmonary Disease $131,554
James Pope, Md, MD
Pulmonary Disease — Payments: $59,197
Pulmonary Disease $59,197
John Russomanno, Md, MD
Pulmonary Disease — Payments: $16,927
Pulmonary Disease $16,927
Richard Zuwallack, Md, MD
Pulmonary Disease — Payments: $6,630
Pulmonary Disease $6,630
Phyllis Schatz, Md, MD
Pulmonary Disease — Payments: $5,543
Pulmonary Disease $5,543
Prashant Grover, M.d, M.D
Pulmonary Disease — Payments: $4,099
Pulmonary Disease $4,099